Received Jan 6, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| ANTH | ANTHRAX (BIOTHRAX) | EMERGENT BIOSOLUTIONS | 6 | 30211A | SYR / LA |
| TYP | TYPHOID VI POLYSACCHARIDE (TYPHIM VI) | SANOFI PASTEUR | 4 | xia271m | RA |
| YF | YELLOW FEVER (YF-VAX) | SANOFI PASTEUR | UNK | UK223AD | RA |
Within the first 5 hrs of receiving the vaccine I felt ill and fatigue with flu-like symptoms . I also developed a nodule at the site injection. Immediate onset of pink/red skin lesions of face and ears within the first 48hrs. Reported onset of new lesions characterized as initially scaley, peeling, developing erosions with pruritus, burning pain and exacerbated by heat, sweat, shower, outdoor environment. The lesions later developed erosions around eyebrows, cheeks, ears. I was given topical hydrocortisone and topical emollient which were not beneficial and seemed to worsen the symptoms.
None
Common migraine
magnesium oxide 400 mg oral tablet, 400 mg= 1 tab(s), Oral; riboflavin 100 mg oral tablet, 400 mg= 4 tab(s), Oral, Daily; ZyrTEC 10 mg oral tablet, 10 mg= 1 tab(s), Oral, Daily
Amoxicillin, Penicillin, Zophran, Tamiflu
SS-A-ab: Positive (5AUG25); ANA Pattern: Homogenous (5AUG25); ANA Titer: 1:640 (5AUG25); Anti-DSDNA Ab: Positive: (5AUG25); MCHC: 32.4 (5AUG25); ANA Scrn: Positive:1:640(5Aug25); MPV:11.2 (5Aug25); WBC:3.7 (13Sep25); D-Dimer:1.03 (13Sep25); C3 Complement LC Laboratory: 62 (17Sep25); Complement C4 LC: 5mg/dL (17Sep25); BUN Laboratory: 20.2 mg (17Sep25); High Sensitivity Troponin: 18(3Oct,25)